Parenteral Patent Drug S/GSK1265744 has the Potential to be an Effective Agent in Pre-Exposure Prophylaxis Against HIV Infection

Publisher： Bentham Science Publishers

E-ISSN： 2212-4071|8|3|213-218

ISSN： 1574-891X

Source： Recent Patents on Anti-Infective Drug Discovery, Vol.8, Iss.3, 2013-12, pp. : 213-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pre-Exposure Prophylaxis - One More Tool for HIV Prevention

By  

Current HIV Research, Vol. 10, Iss. 2, 2012-03 ,pp. : 117-122

Bentham Science Publishers

Access to resources Recommend Favorite

Predictors of willingness to use HIV pre-exposure prophylaxis among female sex workers in Southwest China

By Jackson Todd   Huang Ailong   Chen Hong   Gao Xiao   Zhang Yan   Zhong Xiaoni  

AIDS Care, Vol. 25, Iss. 5, 2013-05 ,pp. : 601-605

Routledge Ltd

Access to resources Recommend Favorite

HIV pre-exposure prophylaxis trials: socio-economic and ethical perspectives for sub-Saharan Africa

By Selemogo Mpho  

African Journal of AIDS Research, Vol. 7, Iss. 2, 2008-07 ,pp. : 243-247

Routledge Ltd

Access to resources Recommend Favorite

Acceptability of an “on-demand” pre-exposure HIV prophylaxis trial among men who have sex with men living in France

By Lorente Nicolas   Fugon Lionel   Carrieri Maria Patrizia   Andreo Christian   Le Gall Jean-Marie   Cook Emmanuel   Aboulker Jean-Pierre   Capitant Catherine   Molina Jean-Michel   Spire Bruno  

AIDS Care, Vol. 24, Iss. 4, 2012-04 ,pp. : 468-477

Routledge Ltd

Access to resources Recommend Favorite

Social Justice and HIV Vaccine Research in the Age of Pre-Exposure Prophylaxis and Treatment as Prevention

By  

Current HIV Research, Vol. 11, Iss. 6, 2013-09 ,pp. : 473-480

Bentham Science Publishers

Access to resources Recommend Favorite